24-25-dihydroxyvitamin-d-3 and Muscular-Dystrophies

24-25-dihydroxyvitamin-d-3 has been researched along with Muscular-Dystrophies* in 2 studies

Other Studies

2 other study(ies) available for 24-25-dihydroxyvitamin-d-3 and Muscular-Dystrophies

Article	Year
[The effect of osteochin on the dynamics of the course of the myodystrophic process]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1992, Volume: 92, Issue:3 Osteochin (Quinoin, Hungary) efficacy was studied in the treatment of 20 patients with Duchenne's progressive myodystrophy. The drug was administered in a dose of 200 mg a day for a month. A favorable effect of such therapy was observed in all the patients. Osteochin was found to have a correcting effect on Ca-regulating hormone function and to promote stabilization of the myodystrophic process. Topics: 24,25-Dihydroxyvitamin D 3; Calcium Channel Blockers; Drug Evaluation; Humans; Locomotion; Muscular Dystrophies; Parathyroid Hormone; Tablets	1992
Low serum 24,25 dihydroxyvitamin D in Duchenne muscular dystrophy. Neurology, 1984, Volume: 34, Issue:9 Levels of serum 24,25(OH)2D3 (0.69 +/- 0.17 ng/ml) were lower in DMD patients than in age-matched controls (2.13 +/- 0.15 ng/ml). Circulating levels of 1,25(OH)2D3 and 25(OH)D3 were within the accepted normal range. Bearing in mind the proposed pathophysiologic role of calcium in DMD and the influence of vitamin D metabolites on muscle ATP and protein synthesis, as well as on sarcoplasmic reticulum calcium transport and muscle mitochondrial calcium content, the above findings of low or deficient 24,25(OH)2D3 levels in DMD could be meaningful from the etiologic and therapeutic points of view. Topics: 24,25-Dihydroxyvitamin D 3; Adolescent; Adult; Calcium; Child; Dihydroxycholecalciferols; Humans; Muscular Dystrophies	1984

Article

Year

[The effect of osteochin on the dynamics of the course of the myodystrophic process].

Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1992, Volume: 92, Issue:3

Osteochin (Quinoin, Hungary) efficacy was studied in the treatment of 20 patients with Duchenne's progressive myodystrophy. The drug was administered in a dose of 200 mg a day for a month. A favorable effect of such therapy was observed in all the patients. Osteochin was found to have a correcting effect on Ca-regulating hormone function and to promote stabilization of the myodystrophic process.

Topics: 24,25-Dihydroxyvitamin D 3; Calcium Channel Blockers; Drug Evaluation; Humans; Locomotion; Muscular Dystrophies; Parathyroid Hormone; Tablets

1992

Low serum 24,25 dihydroxyvitamin D in Duchenne muscular dystrophy.

Neurology, 1984, Volume: 34, Issue:9

Levels of serum 24,25(OH)2D3 (0.69 +/- 0.17 ng/ml) were lower in DMD patients than in age-matched controls (2.13 +/- 0.15 ng/ml). Circulating levels of 1,25(OH)2D3 and 25(OH)D3 were within the accepted normal range. Bearing in mind the proposed pathophysiologic role of calcium in DMD and the influence of vitamin D metabolites on muscle ATP and protein synthesis, as well as on sarcoplasmic reticulum calcium transport and muscle mitochondrial calcium content, the above findings of low or deficient 24,25(OH)2D3 levels in DMD could be meaningful from the etiologic and therapeutic points of view.

Topics: 24,25-Dihydroxyvitamin D 3; Adolescent; Adult; Calcium; Child; Dihydroxycholecalciferols; Humans; Muscular Dystrophies

1984